首页 | 本学科首页   官方微博 | 高级检索  
     


Total alloplastic temporomandibular joint reconstruction using Biomet stock prostheses: the University of Florida experience
Affiliation:1. Department of Oral and Maxillofacial Surgery, University of Florida, Gainesville, FL, USA;2. Division of Oral and Maxillofacial Surgery, Emory University School of Medicine and Children''s Healthcare of Atlanta, Atlanta, GA, USA;3. Division of Facial Pain, Departments of Orthodontics and Neuroscience, University of Florida, Gainesville, FL, USA;1. Maxillofacial Unit, Royal Shrewsbury Hospital, Shrewsbury SY3 8XQ, UK;2. Regional Maxillofacial Unit, University Hospital Aintree, Liverpool L9 7LN, UK;3. Regional Maxillofacial Unit, University Hospital Aintree, Liverpool L9 7LN, UK;4. Maxillofacial Unit, Queens Medical Centre, Nottingham NG7 2UH, UK;5. Maxillofacial Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK;6. Maxillofacial Unit, Bradford Teaching Hospitals, Bradford BD9 6RJ, UK;1. TEMA, Department of Mechanical Engineering, University of Aveiro, Portugal;2. Université de Bordeaux, Institut de Mécanique et d''ngénierie, CNRS UMR 5295, Talence, France;1. Clinical Professor, Departments of Oral and Maxillofacial Surgery and Orthodontics, Texas A&M University Health Science Center, Baylor College of Dentistry, and Private Practice, Baylor University Medical Center, Dallas, TX;2. Former Fellow, Department of Oral and Maxillofacial Surgery, Texas A&M University Health Science Center, Baylor College of Dentistry, Dallas, TX, and Clinical Assistant Professor, Department of Orthodontics, Center for Advanced Dental Education, St Louis University, St Louis, MO;3. Attending Surgeon, Department Oral Maxillofacial Plastic Surgery, University Hospital Bonn, Bonn, Germany;4. Institute for Medical Biometry, Computer Science and Epidemiology, University Hospital Bonn, Bonn, Germany;6. Former Resident, Department of Oral and Maxillofacial Surgery, Texas A&M University Health Science Center, Baylor College of Dentistry, Dallas, TX, and LCDR US Navy, GPR Instructor at Naval Hospital, Camp Pendelton, CA;5. Professor, Department of Biomedical Sciences, Texas A&M University Health Science Center, Baylor College of Dentistry, Dallas, TX;1. Registrar, Oral and Maxillofacial Surgery Unit, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia;2. Consultant Surgeon, John Hunter Hospital, and Private Practice, Newcastle, New South Wales, Australia;3. Professor, Department of Surgery, James Cook University, and Former Consultant Maxillofacial Surgeon, Townsville Hospital, Queensland, Australia;4. Consultant Surgeon, Private Practice, Melbourne, Victoria, Australia
Abstract:The purpose of this study was to report the subjective and objective outcomes of temporomandibular joint (TMJ) replacement with Biomet stock prostheses at a single institution in Florida. In this retrospective study, patients who underwent TMJ replacement using a Biomet stock prosthesis from 2005 to 2012 were analyzed. Subjective (pain, diet) and objective (maximal incisal opening) information was obtained. In addition, a quality of life measure was obtained pre- and postoperatively. Significance was set at <0.01. Thirty-six patients (26 bilateral, 6 left, and 4 right) who underwent TMJ replacement using a Biomet stock prosthesis were eligible for the study. Maximal incisal opening improved from 26.1 mm preoperatively to a mean of 34.4 mm postoperatively. The pain score decreased from 7.9 preoperatively to a mean of 3.8 postoperatively. Diet restriction decreased from 6.8 preoperatively to a mean of 3.5 postoperatively. Quality of life improved from a median of 4 preoperatively to a postoperative median of 2. Four implants were removed/replaced because of heterotopic bone formation, infection, and/or loose hardware. Follow-up ranged from 6 to 83 months. Overall, TMJ reconstruction using the Biomet stock joint is effective and safe in this patient population.
Keywords:total joint prosthesis  temporomandibular joint  biomet
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号